Edwards lifesciences outlines growth strategy at annual investor conference

Irvine, calif.--(business wire)--edwards lifesciences corporation (nyse: ew) will discuss the company's sharpened focus and strategy for longer-term growth, provide an update on its technology pipeline and share financial guidance1 today during its annual investor conference. highlights of today's conference include: expecting early completion of enrollment in progress, studying moderate as patients, in early 2024 expecting data from early tavr, studying severe asymptomatic as patients, at tct.
EW Ratings Summary
EW Quant Ranking